Publication | Closed Access
CXCL11 negatively regulated by MED19 favours antitumour immune infiltration in breast cancer
13
Citations
30
References
2022
Year
Breast OncologyCancer ImmunosurveillanceMedicineImmunologyPathologyImmune InfiltrationImmune Checkpoint InhibitorBreast CancerMed19 FavoursImmunotherapyOncologyTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1